production of monoclonal antibodies

Trastuzumab, a monoclonal antibody used primarily in the treatment of HER2-positive breast cancer, has revolutionized cancer therapy since its introduction. The production of Trastuzumab is a complex and highly regulated process that requires significant financial and technical resources. Understanding the production costs of trastuzumab is crucial for pharmaceutical companies, healthcare providers, and policymakers to ensure …

Continue reading “Trastuzumab Production Cost Report: Comprehensive Analysis”